Gene by Gene

NEW YORK (GenomeWeb) – Scientists from consumer genomics firm 23andMe for the first time described the Mountain View, Calif.-based company's Ancestry Composition tool in a paper.

Gene by Gene will later this year debut a genetic disease carrier screening service focused on Jewish populations in the US.

A new Y chromosome sequencing service could lead to a new generation of more informative microarrays for genetic genealogy and ancestry testing.

The term 'consumer genomics' may have a catch-all ring to it, but for the time being it means ancestry testing and genetic genealogy, including for companies such as 23andMe, which built its business on relaying both personal health information and ancestral information back to c

RootsTech is a family history conference held each year in Salt Lake City.

Gene by Gene can still the return mutation status of the BRCA1 and BRCA2 genes to US and Canadian customers via its clinical and research-focused microarrays, despite a new agreement with Myriad Genetics that prohibits Gene by Gene from offering its BRCA single-gene and gene pane